Pancreatic Cancer Research

ResearcherFirst Hospital of China Medical UniversityActive in the last 2 years

Guosen Wang

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5080179635. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 4 papers · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 7

  1. A Mutual Interaction Between GSTP1 and p53 Improves the Drug Resistance and Malignant Biology of Pancreatic Cancer. Co-author DOI 10.1111/cas.70019↗
  2. Musashi2 promotes the progression of pancreatic cancer through a novel ISYNA1-p21/ZEB-1 pathway. Co-author DOI 10.1111/jcmm.15676↗
  3. Correction to: Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling. Co-author DOI 10.1186/s13046-020-01663-2↗
  4. Calreticulin promotes EMT in pancreatic cancer via mediating Ca2+ dependent acute and chronic endoplasmic reticulum stress. First author DOI 10.1186/s13046-020-01702-y↗
  5. Musashi2 promotes EGF-induced EMT in pancreatic cancer via ZEB1-ERK/MAPK signaling. Co-author DOI 10.1186/s13046-020-1521-4↗
  6. Serine/arginine protein-specific kinase 2 promotes the development and progression of pancreatic cancer by downregulating Numb and p53. Co-author DOI 10.1111/febs.14778↗
  7. Calreticulin promotes EGF-induced EMT in pancreatic cancer cells via Integrin/EGFR-ERK/MAPK signaling pathway. Co-author DOI 10.1038/cddis.2017.547↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Weiwei Sheng · 7 shared papers, 2017–2025 · strength 0.85
  2. Ming Dong · 6 shared papers, 2017–2020 · strength 0.62
  3. Rongxian Cao · 4 shared papers, 2020 · strength 0.43
  4. Chao Jia · 4 shared papers, 2020 · strength 0.43
  5. Jian Hua Sun · 3 shared papers, 2020 · strength 0.32
  6. Jianping Zhou · 3 shared papers, 2017–2020 · strength 0.29
  7. Jiabin Jin · 1 shared paper, 2025 · strength 0.24
  8. Qi Dong · 1 shared paper, 2020 · strength 0.11
  9. Lei Zhou · 1 shared paper, 2020 · strength 0.11
  10. Song He · 1 shared paper, 2017 · strength 0.07
  11. Shuangning Ding · 1 shared paper, 2017 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.